Toronto Dominion Bank
TARS icon

Toronto Dominion Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Toronto Dominion Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1M Hold
510,253
– – 0.04% 382
2026
Q1 		$35.8M Hold
510,253
– – 0.05% 294
2025
Q4 		$41.8M Sell
510,253
-107,330
-17% -$8.01M 0.06% 286
2025
Q3 		$36.7M Sell
617,583
-384,379
-38% -$18.9M 0.06% 290
2025
Q2 		$40.6M Sell
1,001,962
-872,783
-47% -$39.3M 0.07% 236
2025
Q1 		$96.3M Sell
1,874,745
-34,483
-2% -$1.7M 0.19% 94
2024
Q4 		$106M Buy
+1,909,228
New +$86.7M 0.17% 92

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Toronto Dominion Bank's TARS Position: Q2 2026 in Review

Toronto Dominion Bank held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 510,253 shares worth $32.1M. The position accounts for 0.04% of the portfolio, ranked #382.

Toronto Dominion Bank first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $106M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Toronto Dominion Bank held 510,253 shares of Tarsus Pharmaceuticals worth $32.1M as of Q2 2026.
  • Toronto Dominion Bank left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up 0.04% of Toronto Dominion Bank's portfolio in Q2 2026, its #382 holding.
  • Toronto Dominion Bank first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Toronto Dominion Bank's Tarsus Pharmaceuticals position peaked at $106M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.